Growth Metrics

RemSleep Holdings (RMSL) Free Cash Flow Growth (1y) (2011 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 RemSleep Holdings - - -7,636.00 34.09%

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 34.09%
Sep 30, 2025 55.19%
Jun 30, 2025 7.00%
Mar 31, 2025 2.98%
Dec 31, 2024 -6.00%
Sep 30, 2024 -53.07%
Jun 30, 2024 49.92%
Mar 31, 2024 58.35%
Dec 31, 2023 42.50%
Sep 30, 2023 20.18%
Jun 30, 2023 80.89%
Mar 31, 2023 -21.65%
Dec 31, 2022 -194.40%
Sep 30, 2022 -162.77%
Jun 30, 2022 -1,016.94%
Mar 31, 2022 -176.92%
Dec 31, 2021 -77.20%
Sep 30, 2021 -69.43%
Jun 30, 2021 18.84%
Mar 31, 2021 4.94%
Dec 31, 2020 51.87%
Sep 30, 2020 27.74%
Jun 30, 2020 -197.75%
Mar 31, 2020 -27.92%
Dec 31, 2019 -228.76%
Sep 30, 2019 -57.11%
Jun 30, 2019 -58.68%
Mar 31, 2019 -144.07%
Dec 31, 2018 -70.95%
Sep 30, 2018 -99.55%
Jun 30, 2018 -21.40%
Mar 31, 2018 -40.23%
Dec 31, 2017 78.68%
Sep 30, 2017 -839.59%
Jun 30, 2017 -898.59%
Mar 31, 2017 25.34%
Dec 31, 2016 -714.89%
Jun 30, 2016 92.04%
Mar 31, 2016 -10.29%
Dec 31, 2015 84.17%
Dec 31, 2014 -3,210.65%
Dec 31, 2013 96.04%
Sep 30, 2013 -100.02%
Jun 30, 2013 94.57%
Mar 31, 2013 101.29%
Dec 31, 2012 0.88%
Sep 30, 2012 59,985.70%
Jun 30, 2012 -31,873.60%
Mar 31, 2012 8.95%
Dec 31, 2011 65.96%
Sep 30, 2011 108.09%